Attached files
| file | filename |
|---|---|
| EX-32.2 - INTERPACE BIOSCIENCES, INC. | ex32-2.htm |
| EX-32.1 - INTERPACE BIOSCIENCES, INC. | ex32-1.htm |
| EX-31.2 - INTERPACE BIOSCIENCES, INC. | ex31-2.htm |
| EX-31.1 - INTERPACE BIOSCIENCES, INC. | ex31-1.htm |
| EX-10.73 - INTERPACE BIOSCIENCES, INC. | ex10-73.htm |
| EX-4.1 - INTERPACE BIOSCIENCES, INC. | ex4-1.htm |
| 10-K - INTERPACE BIOSCIENCES, INC. | form10-k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Interpace Biosciences, Inc.
Parsippany, New Jersey
We hereby consent to the incorporation by reference in the Registration Statements on Form S-1 (Nos. 333-218140 and 333-218780), Form S-3 (Nos. 333-207263 and 333-227728) and Form S-8 (Nos. 333-61231, 333-60512, 333-177969, 333-201070, 333-214260, 333-252574 and 333-234284) of Interpace Biosciences Inc. of our report dated April 1, 2021, relating to the consolidated financial statements and financial statement schedule, which appears in this Form 10-K. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
/s/BDO USA, LLP
Woodbridge, New Jersey
April 1, 2021